Works by Calvo, Emiliano


Results: 65
    1

    Barriers to publishing early phase clinical trials: the oncologists' perspective.

    Published in:
    Oncologist, 2025, v. 30, n. 4, p. 1, doi. 10.1093/oncolo/oyaf042
    By:
    • Lucassen, Merel J J;
    • Bergmann, Pedro;
    • Husson, Olga;
    • Banerji, Udai;
    • Basu, Bristi;
    • Melero, Ignacio;
    • Calvo, Emiliano;
    • Cassier, Philippe A;
    • Drilon, Alexander;
    • Fong, Peter C;
    • Garralda, Elena;
    • Joshua, Anthony M;
    • Lin, Chia-Chi;
    • Lopez, Juanita;
    • Moreno, Victor;
    • Minchom, Anna;
    • Plummer, Ruth;
    • Postel-Vinay, Sophie;
    • Spreafico, Anna;
    • Shimizu, Toshio
    Publication type:
    Article
    2

    Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-x
    By:
    • Chia-Chi Lin;
    • Calvo, Emiliano;
    • Papadopoulos, Kyriakos P.;
    • Patnaik, Amita;
    • Sarantopoulos, John;
    • Mita, Alain C.;
    • Preston, Glenn G.;
    • Mita, Monica M.;
    • Rodon, Jordi;
    • Mays, Theresa;
    • I.-Tien Yeh;
    • O'Rourke, Pat;
    • Takimoto, Chris H.;
    • Dancey, Janet E.;
    • Chen, Helen;
    • Tolcher, Anthony W.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial.

    Published in:
    Cancers, 2020, v. 12, n. 10, p. 2985, doi. 10.3390/cancers12102985
    By:
    • Chau, Ian;
    • Penel, Nicolas;
    • Soriano, Andres O.;
    • Arkenau, Hendrik-Tobias;
    • Cultrera, Jennifer;
    • Santana-Davila, Rafael;
    • Calvo, Emiliano;
    • Le Tourneau, Christophe;
    • Zender, Lars;
    • Bendell, Johanna C.;
    • Mi, Gu;
    • Gao, Ling;
    • McNeely, Samuel Clark;
    • Oliveira, Joana M.;
    • Ferry, David;
    • Herbst, Roy S.;
    • Fuchs, Charles S.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Study in Patients with Mixed Solid Tumors (GO30103).

    Published in:
    Journal of Clinical Pharmacology, 2024, v. 64, n. 5, p. 544, doi. 10.1002/jcph.2397
    By:
    • Garralda, Elena;
    • Oh, Do Youn;
    • Italiano, Antoine;
    • Bedard, Philippe L.;
    • Delord, Jean‐Pierre;
    • Calvo, Emiliano;
    • LoRusso, Patricia;
    • Wainberg, Zev;
    • Cervantes, Andres;
    • Rodriguez‐Vida, Alejo;
    • Shemesh, Colby S.;
    • Sane, Rucha;
    • Mendus, Diana;
    • Ding, Hao;
    • Hendricks, Robert;
    • Meng, Ray;
    • Cho, Byoung Chul;
    • Kim, Tae Won;
    • Wu, Benjamin
    Publication type:
    Article
    16
    17
    18

    Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma.

    Published in:
    2000
    By:
    • Rodriguez, Javier;
    • Cortes, Javier;
    • Calvo, Emiliano;
    • Azinovic, Ignacio;
    • Fernandez-Hildago, Oscar;
    • Martinez-Monge, Rafael;
    • Garzon, Carlos;
    • de Irala, Jokin;
    • Martinez-Aguillo, Maite;
    • Ramon y Cajal, Teresa;
    • Brugarolas, Antonio;
    • Rodriguez, J;
    • Cortes, J;
    • Calvo, E;
    • Azinovic, I;
    • Fernandez-Hildago, O;
    • Martinez-Monge, R;
    • Garzon, C;
    • de Irala, J;
    • Martinez-Aguillo, M
    Publication type:
    journal article
    19

    Noninfectious Pneumonitis after Everolimus Therapy for Advanced Renal Cell Carcinoma.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2010, v. 182, n. 3, p. 396, doi. 10.1164/rccm.200911-1720OC
    By:
    • White, Dorothy A.;
    • Camus, Philippe;
    • Endo, Masahiro;
    • Escudier, Bernard;
    • Calvo, Emiliano;
    • Akaza, Hideyuki;
    • Uemura, Hirotsugu;
    • Kpamegan, Euloge;
    • Kay, Andrea;
    • Robson, Matthew;
    • Ravaud, Alain;
    • Motzer, Robert J.
    Publication type:
    Article
    20
    21
    22
    23
    24

    A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors.

    Published in:
    Science Translational Medicine, 2023, v. 15, n. 695, p. 1, doi. 10.1126/scitranslmed.abp9229
    By:
    • Melero, Ignacio;
    • Tanos, Tamara;
    • Bustamante, Mariana;
    • Sanmamed, Miguel F.;
    • Calvo, Emiliano;
    • Moreno, Irene;
    • Moreno, Victor;
    • Hernandez, Tatiana;
    • Martinez Garcia, Maria;
    • Rodriguez-Vida, Alejo;
    • Tabernero, Josep;
    • Azaro, Analia;
    • Ponz-Sarvisé, Mariano;
    • Spanggaard, Iben;
    • Rohrberg, Kristoffer;
    • Guarin, Ernesto;
    • Nüesch, Eveline;
    • Davydov, Iakov I.;
    • Ooi, Chiahuey;
    • Duarte, José
    Publication type:
    Article
    25
    26
    27
    28

    Understanding the Preclinical Efficacy of Antibody–Drug Conjugates.

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 23, p. 12875, doi. 10.3390/ijms252312875
    By:
    • Díaz-Tejeiro, Cristina;
    • López de Sá, Alfonso;
    • Poyatos-Racionero, Elisa;
    • Ballestín, Pablo;
    • Bartolomé, Jorge;
    • Calvo, Emiliano;
    • Moreno, Víctor;
    • Moris, Francisco;
    • Pérez-Segura, Pedro;
    • Gyorffy, Balazs;
    • Pandiella, Atanasio;
    • Ocaña, Alberto
    Publication type:
    Article
    29

    Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D.

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5345, doi. 10.3390/ijms25105345
    By:
    • Sanvicente García, Adrián;
    • Pedregal, Manuel;
    • Paniagua-Herranz, Lucía;
    • Díaz-Tejeiro, Cristina;
    • Nieto-Jiménez, Cristina;
    • Pérez Segura, Pedro;
    • Munkácsy, Gyöngyi;
    • Győrffy, Balázs;
    • Calvo, Emiliano;
    • Moreno, Víctor;
    • Ocaña, Alberto
    Publication type:
    Article
    30
    31

    Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2.

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2222, doi. 10.3390/ijms25042222
    By:
    • Paniagua-Herranz, Lucía;
    • Moreno, Irene;
    • Nieto-Jiménez, Cristina;
    • Garcia-Lorenzo, Esther;
    • Díaz-Tejeiro, Cristina;
    • Sanvicente, Adrián;
    • Doger, Bernard;
    • Pedregal, Manuel;
    • Ramón, Jorge;
    • Bartolomé, Jorge;
    • Manzano, Arancha;
    • Gyorffy, Balázs;
    • Gutierrez-Uzquiza, Álvaro;
    • Pérez Segura, Pedro;
    • Calvo, Emiliano;
    • Moreno, Víctor;
    • Ocana, Alberto
    Publication type:
    Article
    32
    33
    34

    Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03790-7
    By:
    • Geva, Ravit;
    • Vieito, Maria;
    • Ramon, Jorge;
    • Perets, Ruth;
    • Pedregal, Manuel;
    • Corral, Elena;
    • Doger, Bernard;
    • Calvo, Emiliano;
    • Bardina, Jorge;
    • Garralda, Elena;
    • Brown, Regina J.;
    • Greger, James G.;
    • Wu, Shujian;
    • Steinbach, Douglas;
    • Yao, Tsun-Wen Sheena;
    • Cao, Yu;
    • Lauring, Josh;
    • Chaudhary, Ruchi;
    • Patel, Jaymala;
    • Patel, Bharvin
    Publication type:
    Article
    35

    First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 417, doi. 10.1007/s00262-021-02973-w
    By:
    • Italiano, Antoine;
    • Cassier, Philippe A.;
    • Lin, Chia-Chi;
    • Alanko, Tuomo;
    • Peltola, Katriina J.;
    • Gazzah, Anas;
    • Shiah, Her-Shyong;
    • Calvo, Emiliano;
    • Cervantes, Andrés;
    • Roda, Desamparados;
    • Tosi, Diego;
    • Gao, Bo;
    • Millward, Michael;
    • Warburton, Lydia;
    • Tanner, Minna;
    • Englert, Stefan;
    • Lambert, Stacie;
    • Parikh, Apurvasena;
    • Afar, Daniel E.;
    • Vosganian, Gregory
    Publication type:
    Article
    36

    The future of oncology therapeutics.

    Published in:
    2017
    By:
    • Mansinho, André;
    • Boni, Valentina;
    • de Miguel, María;
    • Calvo, Emiliano;
    • Mansinho, André;
    • de Miguel, María
    Publication type:
    Editorial
    37

    Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 13, p. 1, doi. 10.1002/cam4.7385
    By:
    • Stradella, Agostina;
    • Johnson, Melissa;
    • Goel, Sanjay;
    • Park, Haeseong;
    • Lakhani, Nehal;
    • Arkenau, Hendrik‐Tobias;
    • Galsky, Matthew D.;
    • Calvo, Emiliano;
    • Baz, Vicente;
    • Moreno, Victor;
    • Saavedra, Omar;
    • Luen, Stephen J.;
    • Mu, Song;
    • Wan, Qiting;
    • Chang, Victoria;
    • Zhang, Wa;
    • Barve, Minal
    Publication type:
    Article
    38
    39
    40

    Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug–Drug Interaction Study.

    Published in:
    Pharmaceuticals (14248247), 2024, v. 17, n. 2, p. 182, doi. 10.3390/ph17020182
    By:
    • Moreno, Irene;
    • Hernández, Tatiana;
    • Calvo, Emiliano;
    • Fudio, Salvador;
    • Kahatt, Carmen;
    • Fernández, Cristian;
    • Iglesias, Jorge Luis;
    • Corral, Gema;
    • Pérez-Ramos, Laura;
    • Montilla, Lola;
    • Zeaiter, Ali;
    • Lubomirov, Rubin
    Publication type:
    Article
    41
    42

    Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony‐Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

    Published in:
    Oncologist, 2021, v. 26, n. 9, p. e1508, doi. 10.1002/onco.13810
    By:
    • Babiker, Hani;
    • Brana, Irene;
    • Mahadevan, Daruka;
    • Owonikoko, Taofeek;
    • Calvo, Emiliano;
    • Rischin, Danny;
    • Moreno, Victor;
    • Papadopoulos, Kyriakos P.;
    • Crittenden, Marka;
    • Formenti, Silvia;
    • Giralt, Jordi;
    • Garrido, Pilar;
    • Soria, Ainara;
    • Hervás‐Morón, Asunción;
    • Mohan, Kosalai Kal;
    • Fury, Matthew;
    • Lowy, Israel;
    • Mathias, Melissa;
    • Feng, Minjie;
    • Li, Jingjin
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study.

    Published in:
    Investigational New Drugs, 2022, v. 40, n. 4, p. 762, doi. 10.1007/s10637-022-01247-1
    By:
    • LoRusso, Patricia;
    • Ratain, Mark J.;
    • Doi, Toshihiko;
    • Rasco, Drew W.;
    • de Jonge, Maja J. A.;
    • Moreno, Victor;
    • Carneiro, Benedito A.;
    • Devriese, Lot A.;
    • Petrich, Adam;
    • Modi, Dimple;
    • Morgan-Lappe, Susan;
    • Nuthalapati, Silpa;
    • Motwani, Monica;
    • Dunbar, Martin;
    • Glasgow, Jaimee;
    • Medeiros, Bruno C.;
    • Calvo, Emiliano
    Publication type:
    Article
    50